跳至主要内容
临床试验/IRCT20161206031256N2
IRCT20161206031256N2已完成2 期

Evaluation of the Effectiveness of Intralymphatic Allergen Immunotherapy in patients with Allergic Rhinitis

Vice chancellor for research, Mashhad University of Medical Sciences0 个研究点目标入组 15 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Patients with Seasonal or Perennial Allergic Rhinitis
  • Aggravated symptoms from mid Summer till mid Autumn for at least two years
  • Age :15-65 years
  • Positive Skin Prick Test response to Salsola Kali
  • Symptoms remain troublesome despite treatment
  • The ability to comply with study procedures

排除标准

  • Past history of Autoimmune Diseases
  • Ongoing Systemic Immunosuppressive treatment.
  • The presence of Pregnancy
  • The presence of Immunodeficiency
  • The presence of Allergic Asthma
  • The presence of Heart Diseases
  • Ongoing Beta Blocker or ACE inhibitors drug usage
  • The presence of Malignancy
  • The presence of any chronic diseases
  • Current symptoms of Upper Respiratory Tract Infection
  • History of life-threatening Anaphylaxis or Angioedema

研究者

发起方
Vice chancellor for research, Mashhad University of Medical Sciences

相似试验